Breaking: Barclays Reaffirms $68 Target Price On Cardinal Health (NYSE:CAH) Shares, Reaffirms Their Original Equal-Weight Rating

April 17, 2018 - By Ann Prendergast

Cardinal Health, Inc. (NYSE:CAH) Logo

Investors sentiment decreased to 0.75 in 2017 Q4. Its down 0.15, from 0.9 in 2017Q3. It dived, as 82 investors sold Cardinal Health, Inc. shares while 236 reduced holdings. 65 funds opened positions while 173 raised stakes. 276.20 million shares or 0.42% more from 275.05 million shares in 2017Q3 were reported.

Regentatlantic Cap reported 0.03% of its portfolio in Cardinal Health, Inc. (NYSE:CAH). Us National Bank De reported 231,738 shares. Ameriprise Fincl owns 270,915 shares or 0.01% of their US portfolio. Jacobs Levy Equity Mngmt invested in 0.41% or 378,953 shares. Moreover, Private Advisor Limited Liability Company has 0.01% invested in Cardinal Health, Inc. (NYSE:CAH). 1St Source Natl Bank has 28,763 shares for 0.14% of their portfolio. Cibc Asset Management Inc invested 0.01% of its portfolio in Cardinal Health, Inc. (NYSE:CAH). First Tru Advisors Ltd Partnership accumulated 659,202 shares or 0.1% of the stock. Bankshares Of America Corp De invested 0.02% in Cardinal Health, Inc. (NYSE:CAH). Lazard Asset holds 0% or 7,902 shares. Hennessy Advsrs accumulated 26,000 shares. Dimensional Fund Advsrs Ltd Partnership reported 1.09 million shares. Moreover, Menta Lc has 0.14% invested in Cardinal Health, Inc. (NYSE:CAH) for 11,925 shares. Citigroup Incorporated holds 285,983 shares or 0.01% of its portfolio. State Board Of Administration Of Florida Retirement Sys holds 0.07% or 454,486 shares in its portfolio.

Since January 22, 2018, it had 0 buys, and 3 sales for $3.82 million activity. On Wednesday, February 14 the insider MORRISON PATRICIA sold $1.89M. 7,995 Cardinal Health, Inc. (NYSE:CAH) shares with value of $549,924 were sold by Giacomin Jon L.

Cardinal Health (NYSE:CAH) Rating Reaffirmed

Barclays now has a $68 target price per share on shares of Cardinal Health (NYSE:CAH). The target price per share would suggest a potential upside of 7.65 % from the last price of Cardinal Health (NYSE:CAH). This rating was disclosed to clients in a note on Monday, 16 April.

Investors sentiment decreased to 0.75 in 2017 Q4. Its down 0.15, from 0.9 in 2017Q3. It dived, as 82 investors sold Cardinal Health, Inc. shares while 236 reduced holdings. 65 funds opened positions while 173 raised stakes. 276.20 million shares or 0.42% more from 275.05 million shares in 2017Q3 were reported.

Regentatlantic Cap reported 0.03% of its portfolio in Cardinal Health, Inc. (NYSE:CAH). Us National Bank De reported 231,738 shares. Ameriprise Fincl owns 270,915 shares or 0.01% of their US portfolio. Jacobs Levy Equity Mngmt invested in 0.41% or 378,953 shares. Moreover, Private Advisor Limited Liability Company has 0.01% invested in Cardinal Health, Inc. (NYSE:CAH). 1St Source Natl Bank has 28,763 shares for 0.14% of their portfolio. Cibc Asset Management Inc invested 0.01% of its portfolio in Cardinal Health, Inc. (NYSE:CAH). First Tru Advisors Ltd Partnership accumulated 659,202 shares or 0.1% of the stock. Bankshares Of America Corp De invested 0.02% in Cardinal Health, Inc. (NYSE:CAH). Lazard Asset holds 0% or 7,902 shares. Hennessy Advsrs accumulated 26,000 shares. Dimensional Fund Advsrs Ltd Partnership reported 1.09 million shares. Moreover, Menta Lc has 0.14% invested in Cardinal Health, Inc. (NYSE:CAH) for 11,925 shares. Citigroup Incorporated holds 285,983 shares or 0.01% of its portfolio. State Board Of Administration Of Florida Retirement Sys holds 0.07% or 454,486 shares in its portfolio.

Since January 22, 2018, it had 0 buys, and 3 sales for $3.82 million activity. On Wednesday, February 14 the insider MORRISON PATRICIA sold $1.89M. 7,995 Cardinal Health, Inc. (NYSE:CAH) shares with value of $549,924 were sold by Giacomin Jon L.

Cardinal Health, Inc. (NYSE:CAH) Ratings Coverage

Among 10 analysts covering Cardinal Health (NYSE:CAH), 1 have Buy rating, 2 Sell and 7 Hold. Therefore 10% are positive. Cardinal Health has $8500 highest and $64 lowest target. $73.44’s average target is 16.26% above currents $63.17 stock price. Cardinal Health had 14 analyst reports since October 24, 2017 according to SRatingsIntel. As per Monday, April 2, the company rating was upgraded by Argus Research. The stock of Cardinal Health, Inc. (NYSE:CAH) has “Hold” rating given on Friday, February 9 by Jefferies. The firm earned “Hold” rating on Tuesday, November 7 by Jefferies. The firm has “Hold” rating by Robert W. Baird given on Wednesday, January 17. The company was maintained on Monday, April 16 by Barclays Capital. On Wednesday, November 15 the stock rating was downgraded by Argus Research to “Hold”. The stock of Cardinal Health, Inc. (NYSE:CAH) earned “Hold” rating by Mizuho on Wednesday, January 24. As per Thursday, February 8, the company rating was maintained by RBC Capital Markets. The stock of Cardinal Health, Inc. (NYSE:CAH) earned “Underweight” rating by Morgan Stanley on Monday, November 20. Mizuho maintained Cardinal Health, Inc. (NYSE:CAH) on Tuesday, October 24 with “Hold” rating.

The stock increased 1.41% or $0.88 during the last trading session, reaching $63.17. About 801,601 shares traded. Cardinal Health, Inc. (NYSE:CAH) has declined 25.57% since April 17, 2017 and is downtrending. It has underperformed by 37.12% the S&P500.

Analysts await Cardinal Health, Inc. (NYSE:CAH) to report earnings on May, 7. They expect $1.51 earnings per share, down 1.31 % or $0.02 from last year’s $1.53 per share. CAH’s profit will be $475.21 million for 10.46 P/E if the $1.51 EPS becomes a reality. After $1.31 actual earnings per share reported by Cardinal Health, Inc. for the previous quarter, Wall Street now forecasts 15.27 % EPS growth.

Cardinal Health, Inc. operates as an integrated healthcare services and products firm worldwide. The company has market cap of $19.88 billion. The company??s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It has a 11.01 P/E ratio. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers.

Cardinal Health, Inc. (NYSE:CAH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: